SCHEMBL8065872

SCHEMBL8065872

COc1cccc(C=CC(=O)Nc2cc(Cl)ccc2C(=O)O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.62
MEN1 O00255 7/20 0.58
KMT2A Q03164 7/20 0.58
MAPT P10636 6/20 0.58
ALDH1A1 P00352 6/20 0.58
TP53 P04637 3/20 0.58
CYP3A4 P08684 3/20 0.58
CYP2C9 P11712 2/20 0.58
MAPK1 P28482 2/20 0.58
CYP2C19 P33261 2/20 0.58
TRPV1 Q8NER1 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
TSHR P16473 1/20 0.58
TRPA1 O75762 2/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
HPGD P15428 3/20 0.56
POLB P06746 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8065870 1.00 GRIK1 (0.62) GRIK1MEN1KMT2AMAPTALDH1A1
SCHEMBL8061715 0.91 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL8061714 0.91 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL2270274 0.88 MEN1 (0.67) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL2270270 0.88 MEN1 (0.67) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL2270277 0.88 MEN1 (0.67) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL8060527 0.87 MAPT (0.72) GRIK1MEN1KMT2AMAPTALDH1A1
SCHEMBL8060530 0.87 MAPT (0.72) GRIK1MEN1KMT2AMAPTALDH1A1
SCHEMBL8059612 0.87 MEN1 (0.65) GRIK1MEN1KMT2AMAPTALDH1A1
SCHEMBL8059615 0.87 MEN1 (0.65) GRIK1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed